
Central China Launches Clinical Trials for Non-Invasive BCI Cap
Tongji Hospital in Central China begins trials of a non-invasive BCI cap, revolutionizing rehab with brain-controlled healing. Phase one done; function recovery tests next.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
Tongji Hospital in Central China begins trials of a non-invasive BCI cap, revolutionizing rehab with brain-controlled healing. Phase one done; function recovery tests next.
China’s WestGene Biopharma receives approval for Phase-I clinical trials of a pioneering mRNA vaccine targeting Epstein-Barr virus positive tumors, marking a significant breakthrough in cancer treatment.